Endothelial function in post-menopausal women: Effect of folic acid supplementation

Human Reproduction

Volumn 19, Issue 4, 2004, Pages 1031-1035

  Paradisi, Giancarlo ^a   Cucinelli, Francesco ^a   Mele, Maria Cristina ^a   Barini, Angela ^a   Lanzone, Antonio ^b   Caruso, Alessandro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Endothelium; Folic acid; Menopause

Indexed keywords

FOLIC ACID; GLUCOSE; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHIONINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL INJURY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; INCIDENCE; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; NORMAL HUMAN; POSTMENOPAUSE; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 1842427743     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh189     Document Type: Article

References (32)

1. Aronow WS and Ahn C (2000) Increased plasma homocysteine is an independent predictor of new coronary events in older persons. Am J Cardiol 8,346-347.
2. Celermajer DS, Sorensen KE and Gooch VM (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340,1111-1115.
3. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE and Hennekens CH (1987) Menopause and the risk of coronary heart disease in women. N Engl J Med 316,1105-1110.
4. Doshi SN, McDowell IF, Moat SJ, Lang D, Newcombe RG, Kredan MB, Lewis MJ and Goodfellow J (2001) Folate improves endothelial function in coronary artery disease: An effect mediated by reduction of intracellular superoxide? Arterioscler Thromb Vasc Biol 21,1196-1202.
5. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ and Goodfellow J (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105,22-26.
6. Falkeborn M, Schairer C, Naessen T and Persson I (2000) Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol 53,832-837.
7. Holven KB, Holm T, Aukrust P, Christensen B, Kjekshus J, Andreassen AK, Gullestad L, Hagve TA, Svilaas A, Ose L et al (2001) Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects. Am J Med 110,536-542.
8. Kannel WB, Hjortland MC, McNamara, PM and Gordon T (1976) Menopause and risk of cardiovascular disease: The Framingham study. Ann Intern Med 85,447-452.
9. Kuvin JT, Ramet ME, Patel AR, Pandian NG, Mendelsohn ME and Karas RH (2002) A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: Enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. Am Heart J 144,165-172.
10. Lukasky HC, Bolonchuk WW, Hall CB and Siders WA (1986) Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 60,1327-1332.
11. Mayer EL, Jacobsen DW and Robinson K (1996) Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 27,517-527.
12. McGregor D, Shand B and Lynn K (2000) A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron 85,215-220.
13. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK and Baron AD (2001) Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103,1410-1415.
14. Rasmussen LB, Ovesen L, Bulow I, Knudsen N, Laurberg P and Perrild H (2000) Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women. Am J Clin Nutr 72,1156-63.
15. Shechter M, Sharir M, Labrador MJ, Forrester J and Merz CN (2000) Improvement in endothelium-dependent brachial artery flow-mediated vasodilation with low-density lipoprotein cholesterol levels <100 mg/dl. Am J Cardiol 86,1256-1259.
16. Spieker LE, Sudano I, Hurlimann D, Lerch PG, Lang MG, Binggeli C, Corti R, Ruschitzka F, Luscher TF and Noll G (2002) High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 26,1399-1402.
17. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D and Loscalzo J (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91,308-318.
18. Starkebaum G and Harlan JM (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77,1370-1376.
19. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G and Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97,2601-2610.
20. Stroes ES, van Faassen EE, Yo M, Martasek P, Boer P, Govers R and Rabelink TJ (2000) Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circ Res 86,1129-1134.
21. Title LM, Cummings PM, Giddens K, Genest JJ Jr and Nassar BA (2000) Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 36,758-765.
22. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S and Imaizumi T (1999) Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci 96,235-239.
23. Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans HA and Rabelink TJ (1998) 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 97,237-241.
24. Verhoef P (2000) Hyperhomocysteinemia and risk of vascular disease in women. Semin Thromb Hemost 26,325-334.
25. Vermeulen A, Verdonck L and Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84,3666-3672.
26. Weiss N, Feussner A, Hailer S, Spengel FA, Keller C and Wolfram G (1999) Influence of folic acid, pyridoxal phosphate and cobalamin on plasma homocyst(e)ine levels and the susceptibility of low-density lipoprotein to ex-vivo oxidation. Eur J Med Res 15,425-432.
27. Weiss N, Keller C, Hoffmann U and Loscalzo J (2002) Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med 7,227-239.
28. Welch GN and Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338,1042-1050.
29. Woo KS, Chook P, Chan LL, Cheung AS, Fung WH, Qiao M, Lolin YI, Thomas GN, Sanderson JE and Metreweli C (2002) Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med 112,535-539.
30. Woo KS, Chook P, Lolin YI, Cheung AS, Chan LT, Sun YY, Sanderson JE, Metreweli C and Celermajer DS (1997) Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 96,2542-2544.
31. Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C and Celermajer DS (1999) Folic acid improves arterial endothelial function in adults with hyperhomocysteinemia. J Am Coll Cardiol 34,2002-2006.
32. Ziakka S, Rammos G, Kountouris S, Doulgerakis C, Karakasis P, Kourvelou C and Papagalanis N (2001) The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis. Int Urol Nephrol 33,559-562.